Replies to post #14178 on Ariad Pharmaceuticals Inc fka ARIA

[bellweather1]

And, despite being a heavily pretreated(and multiple tx failure) population, the only 2 pts that failed to reach this critical level> MCyR(in PhaseI), were only on 2-4mg of Pona, due to dose escalation.

Really amazing and impressive!

800 days and counting!

Now it's about time to see a little comparable durability and continued improvement from the stock.

[DewDiligence]

no patient has failed if they reached complete…

Within the confines of this trial, isn’t such an assertion semi-tautological?